We usually link small-vessel disease (SVD) of the brain with ageing, hypertension, or long-term diabetes. It's classified as a cerebrovascular disorder that develops gradually over time.

But what if we're missing out on early warning signs in a younger demographic, specifically, those who report with inexplicable, recurring headaches? As a neurologist, I believe this subject merits more investigation.

The Headache Conundrum for the Young

Young individuals sometimes dismiss persistent headaches as stress, migraine, or lifestyle issues. Many clinicians agree, particularly when neurological examinations and basic imaging show normal. However, there is a growing recognition that in some situations, the problem may reside deeper in the brain's microvasculature.

Small-vessel disease affects the tiny arteries and arterioles that provide blood to the deep tissues of the brain. While its full-blown form usually manifests as white matter alterations, small strokes, or cognitive loss in older persons, early symptoms might be far more subtle, such as a shift in headache patterns or new-onset migraines with aura.

What We Might be Missing

MRI scans, particularly those performed with high-resolution sequences such as FLAIR (Fluid-Attenuated Inversion Recovery), can detect early symptoms of small-vessel involvement in people under 40. These may manifest as modest white matter hyperintensities, which are frequently ignored as "nonspecific changes" or "incidental findings."

However, in a patient with a history of recurrent headaches, moderate hypertension, autoimmune disease, smoking, or metabolic syndrome, these findings merit further investigation.

In other cases, they may signify the early onset of cerebral small-vessel pathology, a developing disorder that, if left untreated, can cause headaches as well as long-term cognitive difficulties.

Why Does It Happen to the Young?

While age remains the most important risk factor for SVD, lifestyle and environmental factors are changing the picture. Risk factors such as poorly regulated blood pressure, obesity, sedentary habits, and chronic inflammation are increasingly surfacing earlier in life.

Hypertension: In young adults, borderline or white-coat hypertension can affect endothelial function in brain arteries.

Autoimmune Disorders: Autoimmune disorders, such as lupus or vasculitis, can affect tiny cerebral vessels.

Chronic Inflammatory States: High-sensitivity CRP and other low-grade inflammation markers have been associated to microvascular damage.

Genetic Predisposition: Rare family types of SVD, such as CADASIL, frequently present with migraine-like headaches prior to stroke.

How Should We Approach it Clinically?

We must resist the temptation to attribute every headache in a young adult to tension or migraine, especially if the headache is progressive, variable in nature, or accompanied by modest neurological complaints such as concentration problems or brief visual impairments.

Detailed History: Inquire about cardiovascular risk factors, autoimmune history, migraine patterns, sleep habits, and substance abuse.

MRI: If you notice any red signs, consider ordering an MRI. In rare cases, an MR angiography might help identify minor vascular abnormalities.

Blood tests: Inflammation indicators, autoimmune panels, and metabolic workups are all important tools.

Lifestyle Interventions: This cannot be stressed enough. Diet, regular exercise, smoking cessation, and blood pressure control all contribute to vascular health.

Is it time to update the guidelines?

The majority of headache care procedures are created with typical differentials in mind: tension headaches, migraines, cluster headaches, or secondary causes such as tumours and infections. Small-vessel disease, particularly in its early stages, does not appear prominently in most diagnostic paths for young adults. This needs to change.

We need to adopt a more vascular-aware approach to neurology. The brain, after all, is only as healthy as the veins that supply it.

Implications for Future

Early-onset small-vessel disease can cause cumulative damage over time. Minor white matter abnormalities may eventually predispose individuals to early cognitive decline, gait difficulties, or mood issues.

We can interfere while the brain is still resilient. We can detect at-risk individuals earlier than ever before by improving screening, providing lifestyle counselling, and using imaging wisely.

If you're a clinician treating a young adult who has inexplicable, recurring headaches, take a moment to explore beyond the obvious. The symptoms may not be limited to stress or migraines; they could even be a quiet cry from the brain's tiny capillaries.

And for patients, if your headaches are changing or feel different from anything you've had before, don't ignore them. A thorough evaluation may not only bring relief, but also preserve your long-term brain health. Let's start paying more attention to what headaches are truly telling us, especially in the young.

Disclaimer: The views expressed in this article are of the author and not of Health Dialogues. The Editorial/Content team of Health Dialogues has not contributed to the writing/editing/packaging of this article.
Dr Avinash Kulkarni
Dr Avinash Kulkarni

Dr Avinash Kulkarni (MBBS, MD (General Medicine), DM (Neurology), MRCP SCE (Neurology), Fellowship in Neuroimmunology) is a Consultant Neurologist at Gleneagles BGS Hospital, Kengeri, Bengaluru, with over 7 years of experience in Neurology. He completed his General Medicine training and pursued Neurology specialization at the prestigious Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Thiruvananthapuram. Following this, he undertook a post-doctoral fellowship in Neuroimmunology at NIMHANS, Bengaluru. Dr Kulkarni specializes in managing multiple sclerosis and related demyelinating disorders, autoimmune encephalitis, stroke, headache disorders, sleep-related conditions, epilepsy, neuropathies, muscle diseases, dementia, Parkinson’s disease, and other movement disorders. His clinical interests extend to Neuroimmunology, Electrophysiology, Sleep Medicine, and Neurorehabilitation. He was recognized as an International Sleep Disorders Specialist by the World Sleep Society in 2024. His original research on sleep-related problems in stroke survivors earned the Best Paper Award at the National Stroke Conference 2023. Dr Kulkarni also received a travel grant to present this work at the World Stroke Congress 2024 in Abu Dhabi, UAE. Additionally, he has completed the MRCP SCE Neurology certification from the UK and has presented numerous papers at national conferences.